Ultragenyx Pharmaceutical (RARE) Share-based Compensation (2013 - 2018)
Ultragenyx Pharmaceutical (RARE) reported Share-based Compensation of $19.56 million for Q2 2018, up 16.5% from $16.79 million a year earlier and up 4.1% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Share-based Compensation (2013 - 2018) Analysis & Trends
Over the twelve months ended Jun 30, 2018, Ultragenyx Pharmaceutical's Share-based Compensation came in at $75.08 million, up 28.3% year-over-year; for FY2017, it came in at $68.01 million, up 40.8% from FY2016.
- Share-based Compensation has increased for four consecutive years, with a five-year compound annual growth rate of 138.0% (FY2012 to FY2017).
- By year, Share-based Compensation came in at $48.31 million in FY2016 (+94.1%), $24.88 million in FY2015 (+361.3%), $5.39 million in FY2014 (+721.0%) and $657,000 in FY2013 (-26.3%).
- The Q2 2018 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2013.
- Year over year, Share-based Compensation has now increased in each of the last 15 quarters, with growth averaging 41.1% over the last eight quarters.
- The year-over-year growth in Share-based Compensation has ranged between 16.5% (Q2 2018) and 852.9% (Q4 2014) over the last five years.
- Per Business Quant data, the three quarters before Q2 2018 came in at $18.8 million (Q1 2018), $19.54 million (Q4 2017) and $17.18 million (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 19.56 Mn |
| Mar 31, 2018 | 18.80 Mn |
| Dec 31, 2017 | 19.54 Mn |
| Sep 30, 2017 | 17.18 Mn |
| Jun 30, 2017 | 16.79 Mn |
| Mar 31, 2017 | 14.50 Mn |
| Dec 31, 2016 | 13.54 Mn |
| Sep 30, 2016 | 13.69 Mn |
| Jun 30, 2016 | 10.86 Mn |
| Mar 31, 2016 | 10.22 Mn |
| Dec 31, 2015 | 9.49 Mn |
| Sep 30, 2015 | 7.90 Mn |
| Jun 30, 2015 | 5.09 Mn |
| Mar 31, 2015 | 2.41 Mn |
| Dec 31, 2014 | 2.00 Mn |
| Sep 30, 2014 | 1.65 Mn |
| Jun 30, 2014 | 946,000.00 |
| Mar 31, 2014 | 795,000.00 |
| Dec 31, 2013 | 210,000.00 |
| Sep 30, 2013 | 71,000.00 |
API Access
Ultragenyx Pharmaceutical Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();